Recent Press Releases

SillaJen Announces Agreement to Acquire Jennerex, Inc.

BUSAN, South Korea & SAN FRANCISCO--SillaJen, Inc., a privately-held biotherapeutics and contract research company focused on the development of targeted biological products for cancer, announced...

Evoke Pharma Selects SynteractHCR as Contract Research Organization for Phase 3 Trial of EVK-001 for Gastroparesis

SAN DIEGO -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the selection of SynteractHCR, Inc. to...

Quintiles Infosario Safety System Wins Best Technological Development

RESEARCH TRIANGLE PARK, N.C. – Quintiles has received Scrip Awards' Best Contract Research Organization honors for the second year running, and Best Technological Development in Clinical...

Harlan Laboratories Announces Expansion of Imaging Services and Availability of Disease-Validated Models at Israel Research Center

INDIANAPOLIS -- Harlan Laboratories, a leading contract research organization and research models and services company, is pleased to announce that the company has expanded its disease-preconditioned...

Pharmacyclics and Catalent Solidify Partnership on the Recently Approved Oncology Therapy, IMBRUVICA™

Somerset, NJ —Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced it has...

ResearchDx, the Leading Contract Diagnostics Organization, Expands Operations into India

MUMBAI--ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets. As part of this...

Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials

PRINCETON, N.J. and FT. MYERS, Fla. -- Covance Inc. (NYSE: CVD), one of the world's largest and most comprehensive drug development services companies, and NeoGenomics, Inc. (NASDAQ: NEO), a...

Vietnam Ministry of Health and Quintiles Collaborate to Advance Clinical Trial Excellence

SINGAPORE – 20 November 2013 – The Vietnam Ministry of Health's Administration of Science, Technology and Training (ASTT) has signed an agreement with Quintiles to enhance clinical...

DATATRAK International, Inc. Reports Record Breaking Third-Quarter 2013 Results

$22M in Backlog Sets Company Record Net Profit Driven by Strong Sales CLEVELAND -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical(R)...

WuXi PharmaTech to Partner with Pharmacyclics

SHANGHAI -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today...

Catalent's Clinical Trial Supply Facility in Shanghai, China Opens for Business

Somerset, NJ – Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced that...

Quintiles Advances Risk-based Monitoring with the Launch of Data-driven Trial Execution Powered by Infosario™ Clinical

New offering improves the quality and predictability of clinical development while reducing overall trial costs by up to 25 percent RESEARCH TRIANGLE PARK, NC – Quintiles today announced the...

ICON Launches New Analytics Service for Advanced Medical Review of Laboratory Data

CONIK Labs allows visualisation, analysis and reporting on laboratory data in real time Dublin, Ireland, 13 November, 2013 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced...

WuXi PharmaTech Announces Third-Quarter 2013 Results

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations...

Acquisition Boosts PRA's Global Phase I Presence

RALEIGH, N.C. – Novenber 13, 2013 – PRA, a leading clinical research organization, today announced its intent to acquire privately held CRI Lifetree, a specialized research organization....

ImmunoGen, Inc. Announces Fifth New License Agreement in 2013

WALTHAM, Mass.--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer therapeutics, today announced that Novartis has licensed the exclusive right to use the...

SYNEXUS CONTINUES TO BUILD IN EASTERN EUROPE, OPENING A NEW REGIONAL CENTER TO SUPPORT GLOBAL CLINICAL TRIALS

Synexus has today opened a regional office for Eastern Europe in Wroclaw, Poland. The investment reflects Synexus' continued commitment to the region and has been created to service the...

CEL-SCI ANNOUNCES INITIATION OF ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION

Vienna, VA -- CEL-SCI Corporation (NYSE MKT: CVM) announced today that it has initiated an arbitration claim against inVentiv Clinical, LLC (f/k/a PharmaNet, LLC and PharmaNet GmbH (f/k/a PharmaNet...

Bend Research Announces Major Investment in Commercial Spray-Dried Dispersion (SDD) Manufacturing

Bend, Ore.--Bend Research Inc., part of Capsugel's Dosage Form Solutions (DFS) business unit, announced today an investment of more than $20 million to expand commercial manufacturing for...

AMRI Announces Lifting of FDA Warning Letter Related to Burlington, Mass. Facility

ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced that it has received a close-out letter from the U.S. Food and Drug Administration lifting a 2010 warning letter related to its Burlington, Massachusetts...